Nanjing Healed Gene Biotechnology Co., Ltd. was established in October 2023, the company focuses on the detection and treatment of depression, and the future business of the company will focus on the entire field of brain science. At present, we have completed the development of fluorescence quantitative PCR, molecular fluorescence hybridization, nucleic acid drugs and other technical platforms for blood and saliva samples, which can be used for rapid and accurate quantitative diagnosis and risk assessment of depression, providing objective biological indicators for the diagnosis of depression, and can be applied to hospital diagnosis, out-of-hospital physical examination, public self-testing and other scenarios.